Grants and Contributions:
Title:
195243
Agreement Number:
195243
Agreement Value:
$2,896,394.00
Agreement Date:
Sep 10, 2010 - Aug 31, 2012
Description:
Soricidin-Derived Peptides for Targeted Cancer Management
Organization:
Atlantic Canada Opportunities Agency
Location:
Moncton, New Brunswick, CA E1C 4W7
Reference Number:
276-2010-2011-Q2-00287
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Additional Information:
The assistance type is Conditionally Repayable Contribution. The total government funding is $3,393,394.00.
Recipient's Legal Name:
Soricimed Biopharma Inc.
Program:
Atlantic Innovation Fund (AIF) - II